Fujifilm: 4 billion investment in semiconductor materials, target 10% EUV photoresist market share

Oct. 18, 2021

Fujifilm: 4 billion investment in semiconductor materials, target 10% EUV photoresist market share


With the surge in global demand for 5G and AI chips, Fujifilm Holdings will invest US$637 million in its semiconductor materials business within the three years ending March 2024.


Fujifilm is a famous Japanese manufacturer of fine chemical manufacturing, film, storage media and cameras. As the traditional film business is shrinking, the company has boldly transformed in recent years and implemented a business diversification strategy, covering key areas such as imaging, printing, medical health, and high-performance materials.

The amount of investment in semiconductor materials (70 billion yen, equivalent to about 4.128 billion yuan) increased by about 40% compared with the previous three-year plan, highlighting that in the context of the lack of core, the global demand for chips is still huge in the future.


Fujifilm's goal is to increase its semiconductor material revenue by approximately 30% to 150 billion yen (approximately RMB 8.846 billion) by the year ending in March 2024, making it the same as the healthcare business to promote company operations The main driver of growth.


Fujifilm will start producing EUV photoresist as soon as this year


At present, EUV photoresist is receiving more and more attention. Whether a high-end EUV photoresist can be manufactured will also become a key criterion for a country and an enterprise to gain a place in the future lithography technology.

Fujifilm is very concerned about the development of EUV photoresist business. According to the Nikkan Kogyo Shimbun reported in January this year, Fujifilm has officially launched the EUV photoresist business, aiming to gain 10% of the global market share by 2024. The company will strengthen the production of extreme ultraviolet (EUV) photoresist, which can be used to produce 5nm or more advanced chips.


As part of the semiconductor material investment plan, Fujifilm will invest 4.5 billion yen (equivalent to approximately 265 million yuan) in its factory in Shizuoka Prefecture, Japan, and begin production of EUV photoresist as soon as this year.


The factory is a subsidiary of Fujifilm-Fuji Electronic Materials (FFEM), which is engaged in semiconductor materials business. It is invested and constructed in Shizuoka Prefecture and installed the most advanced semiconductor material quality assessment equipment for EUV process. The company will introduce the most advanced inspection equipment this time to improve quality and ensure stable supply. The company's experience in producing ArF photoresist also contributes to the development and production of new products.


In addition, Fujifilm produces six materials for chip manufacturing, such as photoresist and chemical mechanical polishing slurry, in 11 factories located in Japan, the United States, Europe, South Korea and China. It will also expand the production capacity of other semiconductor materials in the United States. In addition, the company also plans to use part of the 70 billion yen (equivalent to about 4.128 billion yuan) of funds for research and development.


Fujifilm's net profit in the first quarter of fiscal 2021 increases by 108%


Fujifilm Holdings Co., Ltd. (Fujifilm) released its financial report for the first quarter of fiscal year 2021 in August 2021.

According to data, the company achieved sales revenue of 582.7 billion yen (equivalent to approximately 34.362 billion yuan) in the first quarter (2021.04-2021.06), a year-on-year increase of 27.7%; and achieved operating profit of 56.3 billion yen (equivalent to approximately 3.32 billion yuan), a year-on-year increase An increase of 176.2%; net profit attributable to shareholders of the parent company was 57.3 billion yen (equivalent to approximately RMB 3.379 billion), a year-on-year increase of 108.4%. Among them, sales in the medical and health field, including the medical system business and the biological CDMO business, have increased significantly.


Whatsapp Skype E-mail WeChat

fengzhizi273239